Table of Contents
Birth Control and Teen Girls' Mental Health: The Research Most Parents Haven't Seen
A major Danish study of 1.1 million women found hormonal birth control significantly increases depression risk — with the effect strongest in adolescents. Here's what the research shows and what parents should know.
Hormonal contraception is prescribed to approximately 1.9 million U.S. teenage girls annually. Many of these prescriptions are for reasons beyond contraception: acne, menstrual regulation, endometriosis, and PMDD. The medications are considered so routine that the mental health risk question rarely makes it into a clinical conversation.
That may be changing. A landmark 2016 Danish register study — tracking over 1.1 million women across more than a decade — found that hormonal contraceptive use was associated with a significantly increased risk of first depression diagnosis and first antidepressant use. The effect was largest among adolescents, for whom combined oral contraceptives were associated with an 80% relative increase in depression risk compared to non-users.
A 2023 follow-up analysis in PLOS Medicine found similar patterns with progestin-only contraceptives, extending the concern beyond combined pills. Teen girls’ mental health is in measurable crisis across all metrics. The question of whether one of the most commonly prescribed medications for teen girls may contribute to that crisis deserves direct examination.
What the Research Shows — and the Important Caveats
The Danish study (Skovlund et al., 2016) followed 1,061,997 women ages 15-34 without prior depression diagnosis from 1995 to 2013. Key findings:
- Women using combined oral contraceptives had a 23% higher relative risk of first antidepressant use compared to non-users
- Women using progestin-only pills had a 34% higher relative risk
- Adolescents aged 15-19 had substantially higher relative risks than adult women — combined pill users in this age group showed ~80% higher relative risk of antidepressant use
- The risk was highest in the first year of use and declined with continued use
Important methodological caveats:
- Relative risk increases look large but absolute risk remains low (from roughly 1.7% to 2.2% per year for first antidepressant use)
- Confounding is a concern — girls who choose contraception may differ from those who don’t in ways that affect depression risk
- This is an observational study; causation is not established
That said: the Danish study is one of the largest and most methodologically rigorous studies in women’s health. The adolescent-specific signal has been replicated in subsequent studies. The research does not prove causation, but it is not easily dismissed.
Why Adolescents May Be More Vulnerable
The developing adolescent brain differs from the adult brain in ways that may make hormonal interventions more consequential:
Adolescent brain development is sensitive to sex hormone fluctuations. The teenage years involve rapid hormonal changes that are deeply intertwined with brain development. Introducing exogenous hormones during this period may interact with developmental processes in ways that don’t occur in adult women.
Mood regulation systems are still maturing. The prefrontal cortex — the brain region most involved in emotional regulation — is not fully developed until the mid-20s. Adolescents are more vulnerable to mood dysregulation from any source, including hormonal.
Progestin sensitivity varies. Different progestin formulations have different interactions with the brain’s progesterone and androgen receptors. Some progestins — particularly those with higher androgenic activity — show stronger associations with depressive symptoms.
Which Methods Show Different Risk Profiles
| Contraceptive Type | Depression Risk Signal | Key Research | Notes |
|---|---|---|---|
| Combined oral contraceptive (estrogen + progestin) | Moderate in adults; higher in teens | Skovlund 2016, multiple replications | Risk varies by progestin type |
| Progestin-only pill (“mini-pill”) | Moderate | PLOS Medicine 2023 | Less studied in teens |
| Hormonal IUD (Mirena, Liletta) | Low-to-moderate signal | Mixed evidence | Localized release reduces systemic exposure |
| Copper IUD (non-hormonal) | No hormonal effect | Reference standard | Appropriate for hormone-sensitive individuals |
| Hormonal implant (Nexplanon) | Moderate signal | Some studies | High-dose continuous progestin |
| Hormonal patch | Similar to pill | Limited teen-specific data | Skin absorption may affect bioavailability |
| Depot medroxyprogesterone (Depo-Provera) | Strongest signal | Multiple studies | Particularly associated with mood side effects |
Legitimate Medical Uses in Teens
The complexity here is real: hormonal contraception has legitimate medical uses beyond pregnancy prevention that often aren’t fully considered in the mental health conversation.
Endometriosis: An estimated 10% of females have endometriosis. Hormonal suppression is often the primary treatment option, with non-hormonal alternatives limited.
PMDD (premenstrual dysphoric disorder): Severe premenstrual mood symptoms respond to hormonal treatment for some patients — including drospirenone-containing pills specifically approved for PMDD.
Severe acne: Hormonal acne treatment has documented effectiveness where antibiotics and topical treatments have failed.
In these cases, the risks and benefits look different than for contraception-only use. Untreated endometriosis pain, severe PMDD, and disfiguring acne also carry mental health consequences.
What Parents Can Reasonably Ask
Parents whose daughters are being prescribed hormonal contraception — for any reason — can ask:
- “What is the specific progestin in this formulation, and does it have a lower androgenic activity option?”
- “Is there a non-hormonal alternative that would address this same condition?”
- “What mental health monitoring do you recommend during the first year?”
- “If my daughter develops depressive symptoms, how do we attribute them vs. the medication?”
These aren’t adversarial questions. They’re the questions the research supports asking.
FAQ
Should I refuse to let my daughter go on birth control?
That’s not what the research supports. Unintended pregnancy in adolescence has serious consequences, and many legitimate medical indications for hormonal contraception exist. What the research supports is informed consent — including mental health risk — and monitoring.
How common are mental health side effects from the pill?
Absolute rates are low. The relative increases found in research (23-80% depending on formulation and age) translate to small absolute risk increases at the individual level. Most teen girls on hormonal contraception do not develop clinical depression as a result.
Are non-pill options safer for mental health?
The copper IUD has no hormonal effects and therefore no hormonal mood risk. For adolescents with depression history or significant family history of mood disorders, discussing the copper IUD as an option is reasonable.
About the author
Ricky Flores is the founder of HiWave Makers and an electrical engineer with 15+ years of experience building consumer technology at Apple, Samsung, and Texas Instruments. He writes about how kids learn to build, think, and create in a tech-saturated world. Read more at hiwavemakers.com.
Sources
- Skovlund, C. W., et al. (2016). Association of hormonal contraception with depression. JAMA Psychiatry, 73(11), 1154–1162. https://doi.org/10.1001/jamapsychiatry.2016.2387
- Zethraeus, N., et al. (2023). Hormonal contraception and mental health: An updated review. PLOS Medicine, 20(4), e1004188. https://doi.org/10.1371/journal.pmed.1004188
- Skovlund, C. W., et al. (2018). Association of hormonal contraception with suicide attempts and suicides. American Journal of Psychiatry, 175(4), 336–342.
- American College of Obstetricians and Gynecologists. (2024). Adolescents and long-acting reversible contraception. acog.org. https://www.acog.org
- National Institute of Mental Health. (2024). Depression in women: What you need to know. nimh.nih.gov. https://www.nimh.nih.gov
